Short and medium term outcomes of surgery for patients with hypertrophic obstructive cardiomyopathy

Dominic J Parry1, Robert E Raskin1, Jeffery A Poynter2

  • 1Department of Cardiovascular Surgery, Peter Munk Cardiac Center, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.

Insights

Septal myectomy (SM) for hypertrophic obstructive cardiomyopathy (HOCM) significantly improves symptoms and reduces outflow tract gradients. This surgery offers excellent long-term outcomes with minimal operative risk for HOCM patients.

Area of Science:

  • Cardiovascular Surgery
  • Cardiology
  • Medical Research

Background:

  • Hypertrophic obstructive cardiomyopathy (HOCM) is a condition requiring surgical intervention.
  • Septal myectomy (SM) is a primary surgical treatment for HOCM.
  • Adjunctive procedures, including aortic shortening, may be used in HOCM surgery.

Purpose of the Study:

  • To report a single surgeon's 10-year experience with corrective surgery for HOCM.
  • To evaluate factors influencing long-term outcomes after HOCM surgery.
  • To describe the technique of septal myectomy and aortic shortening in HOCM patients.

Main Methods:

  • Retrospective review of institutional surgical databases from 2001-2011.
  • Analysis of perioperative data for 211 patients undergoing septal myectomy for HOCM.
  • Follow-up included echocardiogram review and telephone interviews for clinical status.

Main Results:

  • Significant improvement in New York Heart Association (NYHA) class and Canadian Cardiovascular Society (CCS) angina grade post-surgery.
  • Marked reduction in left ventricular outflow tract gradient, right ventricular systolic pressure, and mitral regurgitation.
  • Low in-hospital mortality (0.5%) and high survival rates (98.6% at 1 year, 98.1% at 5 years).
  • Predictors of worse outcomes included preoperative NYHA/CCS class, new-onset atrial fibrillation, and female sex.

Conclusions:

  • Septal myectomy provides excellent symptom relief for patients with obstructive HOCM.
  • The surgical procedure is associated with minimal operative risk.
  • Long-term outcomes are favorable, with significant functional improvement and survival.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
442
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
721
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
805
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
472
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
582